Last updated: July 11, 2026

Application No. 19/432,924

Untitled Application

Unknown

Filed

Priority

May 01, 2020 — IN 202021018731 +4 more

Examiner

REGLAS, GEORGIANA C

Art Unit

Tech Center

Kashiv BioSciences, LLC

Assignee

Kashiv Biosciences LLC

OA Round

1 (Non-Final)

This examiner grants 38% of cases after interview

— +30.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 71 resolved cases, 2023–2026

Examiner Intelligence

REGLAS, GEORGIANA C View full profile →

Grants only 38% of cases

Career Allowance Rate

27 granted / 71 resolved

-22.0% vs TC avg

Strong +30% interview lift

Without

With

+30.5%

Interview Lift

resolved cases with interview

Typical timeline

3y 7m

Avg Prosecution

32 currently pending

Career history

120

Total Applications

across all art units

Statute-Specific Performance

§101

2.1%

-37.9% vs TC avg

§103

61.7%

+21.7% vs TC avg

§102

3.0%

-37.0% vs TC avg

§112

6.7%

-33.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 71 resolved cases

Prosecution Timeline

May 04, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/284,104

Patent 12611008

GARMENT, ESPECIALLY SPORTS GARMENT

5y 0m to grant Granted Apr 28, 2026

17/762,263

Patent 12605412

Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments

4y 1m to grant Granted Apr 21, 2026

17/762,582

Patent 12522813

MANNANASE FOR FORMULATIONS HAVING PH 5-12

3y 9m to grant Granted Jan 13, 2026

17/597,140

Patent 12509665

Thioredoxin mutant, preparation method thereof, and application thereof in production of recombinant fusion protein

4y 0m to grant Granted Dec 30, 2025

17/813,467

Patent 12467103

LIGASE FUSION PROTEINS AND APPLICATION THEREOF

3y 3m to grant Granted Nov 11, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

38%

Grant Probability

68%

With Interview (+30.5%)

3y 7m

Median Time to Grant

Low

PTA Risk

Based on 71 resolved cases by this examiner. Grant probability derived from career allowance rate.